Preparing for a Clinician Visit About 7-OH

Bring what you know, and mark what you do not

Bring product packaging or clear label photographs, a short account of what you actually used and when, symptoms you noticed, and a list of other medicines and substances. Keep label claims separate from your own observations, and bring the questions you most want answered.

NIH recommends keeping a supplement and medicine record and sharing it with healthcare providers. This guide adapts that record-keeping idea; it does not establish that a 7-OH product is a supplement, safe, or approved. NIH record-keeping guidance

You do not need a perfect record to ask for help. This guide and its original worksheet are educational, not a diagnostic checklist or a plan for using, stopping, or replacing a product. Neither has undergone qualified medical review or clinical validation.

Download the two-page clinician-visit worksheet (PDF). It is a blank paper record, not a form to submit to this site. Do not send personal health information to this site.

An emergency comes before appointment preparation

If someone cannot be awakened or has slow, shallow, or difficult breathing, do not wait for an appointment or finish these notes. In the United States, call 911 for suspected overdose, give naloxone if available, and stay until emergency help arrives. CDC advises treating uncertainty as a possible overdose rather than waiting to be sure. CDC overdose response guidance

For non-emergency support pathways, see Get Help. A product record must never delay emergency care.

Identify the product, not just the word kratom

7-OH means 7-hydroxymitragynine. FDA's July 29, 2025 clinician letter distinguishes trace amounts in kratom leaf from concentrated 7-OH products and warns about withdrawal and potentially fatal breathing effects. It identifies names such as 7-OHMG, 7-Hydroxy, and 7-HMG. FDA letter to healthcare professionals

Write the exact product name and ingredient wording, even when you are unsure what they mean. Avoid using "kratom" as the only description when the package identifies another ingredient or an enhanced formulation. Show what you have rather than assigning a category yourself.

Keep photographs of the front and back, ingredient panel, serving information, and lot or batch identifier. Include each different product rather than assuming similar branding means the same contents. If packaging is missing, say so; a remembered name is not a confirmed label.

For formulation background, read What Is 7-OH?. For per-tablet versus per-serving claims, use How to Read a 7-OH Product Label.

Separate the label, actual use, and observations

Use three distinct parts in your summary. This is an original editorial organizing framework, not a validated medical assessment.

• Label claim: copy the ingredient, printed amount, units, and whether the claim applies to a tablet, serving, or package. Say "the label says," not that it is a measured amount inside your body.
• Reported use: describe what you actually consumed, in the units you remember, and how you used it. State whether this comes from notes or an estimate. Do not replace your account with the manufacturer's serving instructions.
• Observations: describe what you noticed and when. Use plain language rather than deciding a symptom proves withdrawal, an interaction, or another diagnosis.

A hypothetical explanation is: "This photograph shows the printed claim. My notes describe the tablets I remember using. I noticed a change in sleep afterward, but I do not know its cause." This is invented wording, not a patient story or a claim about a particular product.

Mark uncertain details as "unknown" or "estimated." A label photograph documents a printed claim, not a laboratory measurement. Do not calculate a supposedly safe amount from incomplete information.

Put timing and symptoms on the same timeline

NIH's record includes when a product is used and start/stop dates. For this conversation, extend that idea by pairing reported use with dated observations. NIH supplement and medicine record

• Describe the pattern: daily, some days, or occasional use, and whether it changed. Include approximate start dates and product changes if remembered.
• Note times of day, the most recent use, and variation between days. Keep a typical day separate from an unusually different day.
• Describe symptoms in your own words: when they began, how long they lasted, and what they interrupted, such as sleep, work, or eating.
• If a delay, missed use, or attempt to stop already happened, describe what you noticed. Do not deliberately repeat it to test a theory.
• Include why you started using the product and what you now want help with. A concern about sleep or a wish for help stopping is a care priority, not a diagnosis.

Use existing notes and memory; do not postpone care to collect a certain number of days of data. A sequence describes events, but "after" does not prove "because of." Leave assessment to the clinician.

Include other medicines and substances

Bring a current list of prescription medicines, over-the-counter products, vitamins, herbs, and supplements, with the amount actually taken, frequency, and reason. NIH recommends recording these details and sharing them with healthcare providers. NIH consumer guidance

Also note alcohol and other substances used, with approximate timing when known. Record recent changes or missed prescribed medicines as observations, not instructions to change anything yourself. Ask the clinician or pharmacist to review the whole list rather than deciding alone which entries matter.

Preparing the list is not a reason to add a sleep aid, substitute another substance, or alter a prescribed medicine. This guide supplies no regimen.

Bring questions that lead to a clear next step

NIH's record suggests asking about other products, side effects, and what to do about problems. These questions adapt that conversation-first approach without prescribing answers. NIH appointment-question prompts

• "What information is missing from my product and use history?"
• "How will you evaluate my symptoms and other possible explanations?"
• "Can we review my medicines and other substances together?"
• "What care options fit my concerns and the reason I started using this product?"
• "If I want to stop or change my use, what professional support should I arrange?"
• "What should prompt emergency care, what needs a call to your office, and whom do I contact after hours?"
• "When should we follow up, and can I have the agreed next steps in writing?"

Choose the questions that matter most to you. If the clinician is unfamiliar with 7-OH, offer the FDA healthcare letter as background, not treatment instructions.

Ask about privacy before sharing your notes

You can ask to speak with the clinician without a companion present. If someone helps you prepare, decide together what they will share and whether you want them at the appointment.

Ask the practice:

• "What will be recorded in my chart, and who can access it?"
• "Can anyone with access to my patient portal see these messages or visit notes?"
• "How do proxy access, insurance communications, or my age affect privacy in my situation?"
• "What are the limits of confidentiality, and how should I share sensitive notes?"

These are questions, not assurances about legal protections or a particular clinic's systems. Do not assume a shared device, account, or portal is private. Keep the preparation record somewhere you control and ask the practice how to transmit it. Preparing for care does not require posting identifying details or use history publicly.

Prepare a short summary, then bring it with you

Start with your main concern. Follow with product identity, the separate label/use/observation accounts, relevant dates, other medicines and substances, and priority questions. Missing details can stay missing; the purpose is an honest starting point.

Use the two-page clinician-visit worksheet (PDF) or your own brief notes. Keep the completed record private; this site does not collect it. The worksheet does not assess risk or recommend a treatment.

For support routes, return to Get Help. Bring what you know, make uncertainty visible, and ask for a follow-up plan rather than trying to solve a medical question from a label or online regimen.